Dysregulated proliferation at any stage of hematopoietic cell differentiation can lead to the abnormal accumulation of CD34+ cells in the bone marrow or peripheral blood, making these markers particularly significant for the diagnosis of diseases such as leukemia, characterized by abnormal growth [9]. Here, CD34 is linked to leukemia.